Fundely
3137
Axel Mark
3624
Twenty-four seven
7074
Visumo
303A
Nomura Micro Science
6254
(FY)Apr 30, 2024 | (FY)Apr 30, 2023 | (FY)Apr 30, 2022 | (FY)Apr 30, 2021 | (FY)Apr 30, 2020 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | -243.62%-8.93B | 249.78%6.22B | -71.36%1.78B | 172.79%6.2B | -8.52B |
Net profit before non-cash adjustment | -78.66%645.89M | -2.06%3.03B | 23.62%3.09B | 37.33%2.5B | --1.82B |
Total adjustment of non-cash items | 188.63%222.13M | -188.17%-250.64M | -140.72%-86.98M | 111.53%213.61M | --100.98M |
-Depreciation and amortization | 24.49%60.06M | -9.70%48.25M | 21.03%53.43M | 91.81%44.15M | --23.02M |
-Reversal of impairment losses recognized in profit and loss | --16.24M | --0 | ---- | --4.23M | ---- |
-Disposal profit | -50.08%610K | -90.11%1.22M | 61.74%12.36M | -50.36%7.64M | --15.39M |
-Other non-cash items | 148.39%145.22M | -96.45%-300.11M | -196.93%-152.77M | 151.84%157.6M | --62.58M |
Changes in working capital | -384.78%-9.79B | 380.44%3.44B | -135.13%-1.23B | 133.42%3.49B | ---10.45B |
-Change in receivables | -296.29%-10.5B | 197.60%5.35B | -241.95%-5.48B | 152.99%3.86B | ---7.29B |
-Change in inventory | 235.69%218.7M | -108.43%-161.18M | 431.18%1.91B | 58.18%-577.29M | ---1.38B |
-Change in payables | 134.07%508.34M | -252.12%-1.49B | 282.27%980.94M | -183.61%-538.19M | --643.67M |
-Provision for loans, leases and other losses | 50.93%-96.76M | -263.04%-197.18M | 142.87%120.94M | 22.99%-282.08M | ---366.28M |
-Changes in other current assets | -125.60%-169.9M | -8.40%663.72M | -26.17%724.56M | 144.81%981.43M | ---2.19B |
-Changes in other current liabilities | 134.29%248.5M | -239.87%-724.78M | 1,060.00%518.18M | -67.24%44.67M | --136.35M |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | -244.61%-12.69M | 66.18%-3.68M | 8.36%-10.89M | -77.73%-11.89M | -6.69M |
Interest received (cash flow from operating activities) | 11.65%1.74M | 7.92%1.55M | 14.38%1.44M | -38.22%1.26M | 2.04M |
Tax refund paid | 21.92%-895.86M | -35.95%-1.15B | -177.03%-843.96M | 54.98%-304.65M | -676.66M |
Other operating cash inflow (outflow) | -933.50%-129.04M | 57.24%-12.49M | 82.37%-29.2M | -463.52%-165.58M | 45.55M |
Operating cash flow | -297.13%-9.96B | 465.02%5.05B | -84.37%894.45M | 162.48%5.72B | ---9.16B |
Investing cash flow | |||||
Net PPE purchase and sale | 95.70%-86.69M | -47,737.92%-2.02B | 95.09%-4.22M | -74.68%-85.86M | ---49.15M |
Net investment product transactions | --0 | 5.89%441.25M | 17,667.03%416.69M | 95.12%-2.37M | ---48.61M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | --5.44M |
Net changes in other investments | 92.55%-583K | -249.78%-7.83M | 445.11%5.23M | 87.11%-1.51M | ---11.74M |
Investing cash flow | 94.49%-87.28M | -479.20%-1.58B | 565.42%417.7M | 13.76%-89.75M | ---104.06M |
Financing cash flow | |||||
Net issuance payments of debt | --1.8B | --0 | ---- | ---- | ---- |
Net common stock issuance | 35.00%-65K | -100.01%-100K | --1.53B | ---- | ---700K |
Increase or decrease of lease financing | 52.59%-3.04M | 38.93%-6.42M | 16.16%-10.51M | -4.56%-12.53M | ---11.99M |
Cash dividends paid | 12.50%-721.08M | -796.19%-824.1M | -33.33%-91.96M | 25.11%-68.97M | ---92.1M |
Net other fund-raising expenses | -100.00%-2K | 50.00%-1K | ---2K | ---- | ---1K |
Financing cash flow | 229.52%1.08B | -158.36%-830.62M | 1,846.36%1.42B | 22.22%-81.5M | ---104.78M |
Net cash flow | |||||
Beginning cash position | 22.35%14.45B | 30.15%11.81B | 157.75%9.07B | -72.69%3.52B | --12.89B |
Current changes in cash | -440.02%-8.97B | -3.51%2.64B | -50.74%2.74B | 159.26%5.55B | ---9.37B |
Cash adjustments other than cash changes | ---1K | ---- | 300.00%2K | 50.00%-1K | ---2K |
End cash Position | -62.12%5.47B | 22.35%14.45B | 30.15%11.81B | 157.75%9.07B | --3.52B |
Free cash flow | -430.96%-10.05B | 242.68%3.04B | -84.28%886.09M | 161.22%5.64B | ---9.21B |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |